ClinicalTrials.gg
RecruitingNCT07417436Updated Oct 30, 2026

Effects of Graded Motor Imagery in Individuals With Foot/Ankle Osteoarthritis

An interventional study of Exercise Program and Exercise plus graded motor imagery in Ankle Osteoarthritis and Foot Osteoarthritis, sponsored by Alanya Alaaddin Keykubat University. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Alanya Alaaddin Keykubat University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Updated Oct 30, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 106 studies in Osteoarthritis with a site in Turkey — 22 open to participants now, 29 under way, none of them phase 3. Osteoarthritis · Turkey.

Planned enrollment
61st of 64
24 · median 54
Started
2026
with 13 others
No phase
60 of 106
12 open now
Primary completion
2026-12
later than 19 of 28 live
Registered
90th of 106
by date

Among the 106 studies in Osteoarthritis with a site in Turkey, this one is the 61st largest by planned enrollment of the 64 interventional ones that give a count, is one of 14 that started in 2026, is one of 60 with no phase, reaches primary completion later than 19 of the 28 other live ones, and was the 90th registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

22 of the 106 studies in Osteoarthritis with a site in Turkey are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 106 studies in Osteoarthritis with a site in Turkey, or all of them as a file.
02

Study summary

The aim of our study is to evaluate the effects of graded motor imagery training applied in addition to a structured exercise program in individuals with foot and/or ankle osteoarthritis.

The study population will consist of twenty-four individuals diagnosed with foot/ankle osteoarthritis who applied to the Orthopedics and Traumatology Department of Alanya Alaaddin Keykubat University Education and Research Hospital.

Individuals who volunteer to participate in the study will be invited to participate through face-to-face interviews. The inclusion and exclusion criteria are as follows:

Inclusion criteria:

  • Being 18 years of age or older
  • Having a diagnosis of foot/ankle osteoarthritis confirmed by a specialist physician through clinical and/or radiological examination
  • Experiencing pain in the ankle joint most days for at least three months
  • Agreeing to participate in randomly assigned treatment and follow-up measurements
  • Having a sufficient level of Turkish language comprehension
  • Having a Standardized Mini Mental Test score of at least 24 points

Exclusion criteria:

  • Previous arthrodesis or joint replacement surgery on the affected ankle
  • Physical therapy for ankle osteoarthritis within the last three months
  • Vision or hearing problems that would affect compliance with treatment.
  • Presence of a neuromuscular disease
  • History of intra-articular ankle injections within the last 3 months
  • Initiation of a new disease-specific pharmacological treatment during the study period During the study period, participants will receive one of the physical therapy programs. One group will only participate in the structured exercise program, while the other group will receive graded motor imagery training in addition to the exercise program.Both treatment groups will receive a total of 12 treatment sessions over 6 weeks.

The results of this study may help improve physiotherapy programs for individuals with similar health conditions.

03

Conditions studied

  • Ankle Osteoarthritis
  • Foot Osteoarthritis

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be 18 years of age or older,
  • Have a diagnosis of foot and/or ankle osteoarthritis confirmed by a specialist physician through clinical and/or radiological examination
  • Experience pain in the ankle joint most days for at least three months
  • Agree to participate in randomly assigned treatment and follow-up measurements
  • Have sufficient understanding of the Turkish language
  • Have a Standardized Mini Mental Test score of at least 24 points

Exclusion criteria

Exclusion Criteria:

  • Previous arthrodesis or joint replacement surgery on the affected ankle,
  • Having received physical therapy for ankle osteoarthritis within the last three months
  • Presence of vision or hearing problems that may affect compliance with treatment.
  • Presence of a neuromuscular disease
  • History of intra-articular ankle injections within the last 3 months
  • Initiation of a new disease-specific pharmacological treatment during the study period
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Active comparator
    Exercise Program

    Behavioral: Exercise Program

  • Active comparator
    Exercise and graded motor imagery

    Behavioral: Exercise plus graded motor imagery

Interventions

  • BehavioralExercise Program

    During this intervention, participants will take part in a structured physiotherapy exercise program. The program will be delivered under the guidance of a physiotherapist.

  • BehavioralExercise plus graded motor imagery

    During this intervention, participants will take part in the same physiotherapy exercise program combined with educational sessions.

06

What researchers measure

Primary outcomes

  1. Socio-demographic assessment form

    The names, ages, genders, heights, body weights, dominant side of the lower extremity, occupations, education levels, and medication use of individuals who wish to participate in the study on a voluntary basis will be recorded, along with their phone numbers so that they can be contacted again if necessary. Radiological findings, age, and disease duration will also be included in the clinical evaluation form for individuals with foot/ankle osteoarthritis.

    Time frame: Baseline and after 6 weeks

  2. Pain Intensity Assessment

    Patients' rest, activity, and night pain will be assessed using the Numerical Rating Pain Scale (NPRS). The NPRS is an 11-point scale scored from 0 to 10. A score of zero (0) indicates "no pain," while a score of 10 indicates "the most severe pain imaginable." Participants will be asked to mark the appropriate score on this scale for their foot/ankle pain.

    Time frame: Baseline and after 6 weeks

  3. Pain Threshold Measurement

    In this study, the pressure pain threshold (PPT) is defined as the amount of pressure (kg/cm²) at which pressure sensation is converted into pain. PPT measurements will be performed using a mechanical pressure algometer (Commander™ Algometer, JTECH Medical, Inc.). During the measurements, participants will be asked to verbally inform the tester when the applied pressure first causes pain. The device used has a force gauge that measures force in kilograms (kg) and a round rubber tip with a diameter of 1 cm². Pressure application will be performed at a rate of approximately 0.1 kg/cm²/s. Three repetitions will be performed for each anatomical region, and the average of the measurements will be used in the analyses. A 30-second rest period will be provided between each measurement. During foot measurements, participants will be placed in a long sitting position, and the foot being evaluated will be stabilized by the examiner. Referencing Cavanagh (1987), pressure will be applied to the m

    Time frame: Baseline and after 6 weeks

  4. Gait Analysis

    The BTS G-Walk® Spatio-Temporal Gait Analysis System will be used for gait analysis in the study. Measurements will be performed on a predetermined 10-meter flat walking track . The BTS G-Walk® system works with a wireless sensor (analysis port) placed at the patient's L4-L5 or L5-S1 vertebra level via an elastic belt, and measurement data is transferred to the computer via a Bluetooth connection. This system allows clinicians to analyze spatio-temporal walking parameters obtained during walking, general walking kinematics, and pelvic and spinal movements in three planes. The BTS G-Walk® system provides a detailed analysis by comparing data from the right and left lower extremities with normative values during gait analysis and ensures reliable measurements

    Time frame: Baseline and after 6 weeks

  5. Foot Function Index

    The Foot Function Index is a self-administered questionnaire that assesses multiple dimensions of foot function. The FFI consists of 23 items divided into three subscales that measure the impact of foot pathology on pain, disability, and activity limitation. The minimum change of clinical significance is 7 points for the total scale. The Foot Function Index is widely used in various pathologies and treatments related to foot and ankle problems, such as congenital, acute and chronic diseases, injuries, and surgical corrections .

    Time frame: Baseline and after 6 weeks

  6. Laterality assessment

    Laterization assessment will be performed using the Recognise™ application developed by the Neuro Orthopaedic Institute (NOI). There are versions specific to different parts of the body. The "Recognise™ Foot" application will be used in this thesis study. Using the "Vanilla" mode of the NOI program, foot photos will be presented to participants in random order via their phones. Participants will be asked to indicate whether the image shown belongs to the right or left foot. Both response accuracy and reaction time will be recorded during this assessment. Accuracy will be defined as the percentage of images correctly identified; reaction time will represent the time taken by the participant to distinguish between the right and left foot. If participants cannot respond within 5 seconds to four or more consecutive images, this will be considered inattention, and the test will be repeated. The lateralization assessment will be performed three times for each participant, and the avera

    Time frame: Baseline and after 6 weeks

Secondary outcomes

  1. Joint position sense assessment

    In this study, a universal goniometer, a method recognized in the literature as valid and reliable for Ankle Joint Position Sense (AJPS) assessment, will be used. During the assessment, individuals will be placed in a supine position and their eyes will be closed to eliminate visual cues. The pivot of the goniometer will be placed 1.5 cm below the lateral malleolus, the fixed arm will be parallel to the long axis of the fibula, and the movable arm will be parallel to the long axis of the 5th metatarsal. During this measurement, the goniometer will not come into contact with the individual. During the test, three target angles will be selected from the 10° dorsiflexion, 10° plantar flexion, and 20° plantar flexion angles, which are frequently used in the literature and are important for walking function. The subjects' feet in the neutral position will be brought to the specified target angles, and they will be asked to focus on their ankle positions for 5 seconds. This process will be

    Time frame: Baseline and after 6 weeks

  2. Foot Pressure Assessment

    Measurements will be taken using a pedobarography device to assess foot pressure in a static position. Participants will be given detailed information about the procedure and the measurement process will be explained prior to the measurement. To help participants maintain their balance and focus their attention during the measurement, a point will be marked on the wall three meters ahead, and participants will be asked to focus on this point throughout the measurement. The data displayed on the device screen when participants achieve their balance position will be recorded. As part of the evaluation, the following data will be recorded for analysis: total foot pressure, forefoot pressure, rearfoot pressure , and surface area for the dominant and non-dominant sides.

    Time frame: Baseline and after 6 weeks

  3. Kinesiophobia Assessment

    The Tampa Kinesiophobia Scale (TKS) will be used in the kinesiophobia assessment. The TKS is a 17-item measure consisting of questions related to fear of re-injury, pain anxiety, and fear-avoidance behaviors. Each item is scored using a 4-point Likert scale ranging from 1 to 4, but items 4, 8, 12, and 16 are reverse-scored. The total score ranges from 17 to 68 points; higher scores indicate a higher level of kinesiophobia.

    Time frame: Baseline and after 6 weeks

  4. Quality of Life Assessment

    The Nottingham Health Profile (NHP) will be used to assess participants' health-related quality of life. It is a measure developed to assess an individual's health status in terms of physical, emotional, and social aspects. The questionnaire assesses six dimensions related to health status: pain (8 items), emotional reactions (9 items), energy (3 items), social isolation (5 items), sleep (5 items), and physical activity (8 items). It consists of a total of 38 questions answered as yes (1 point)/no (0 points) (Appendix-6). A score between 0 and 100 can be obtained from each subcategory. '0' indicates no limitation, while '100' indicates the presence of all listed limitations.

    Time frame: Baseline and after 6 weeks

  5. Patient Satisfaction Assessment

    The Global Rating of Change (GRC) scale will be used for patient satisfaction assessment. This scale will be used to measure the effect of the treatment process on participants' overall health status and the level to which their individual expectations are met. Participants will be asked to indicate the change they feel in their health status after treatment compared to before treatment.

    Time frame: End of the intervention

  6. Central Sensitization Assessment

    The central sensitization assessment will be conducted using the Central Sensitization Inventory (CSI). This inventory is an assessment tool used to identify individuals with symptoms related to central sensitization and to screen for clinical conditions associated with central sensitization syndrome (CSS), such as fibromyalgia, temporomandibular joint disorder, tension-type headache, and migraine. The CSI consists of two sections: Section A consists of 25 items that inquire about symptoms specific to central sensitization syndrome. Participants rate each item on a scale of 0 to 4. The total score obtained from this section ranges from 0 to 100, with scores of 40 and above indicating the presence of central sensitization. Section B contains questions aimed at determining whether the participant has previously been diagnosed with psychiatric conditions such as anxiety or depression, or with diseases associated with the CNS.

    Time frame: Baseline and after 6 weeks

07

Study locations

2 of 2 sites recruiting
  • Alanya Alaaddin Keykubat University Training and Research Hospital
    Antalya, Antalya, Turkey (Türkiye)
    Recruiting
  • Alanya Alaaddin Keykubat University Training and Research Hospital
    Antalya, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Dec 2026, 9 months after the start.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 9 months is below that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

Start moved once since we started tracking on Sep 25, 2026: Aug 2025 → Mar 2026, on Oct 30, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 11, 2026
First posted
Feb 18, 2026
StartActual
Mar 10, 2026was Aug 2025
Primary completionEst.
Dec 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Aug 28, 2025→Mar 10, 2026
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    Start date Aug 28, 2025→Mar 10, 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07417436
Lead sponsor
Alanya Alaaddin Keykubat University
Responsible party
ÖZLEM NUR TOK YAMAN (Lecturer, Alanya Alaaddin Keykubat University) — Principal investigator
First posted
Feb 18, 2026
Start date
Mar 10, 2026
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Oct 30, 2026

Study contacts

Özlem Nur Tok Yaman, PhD
Contact
ozlem.tok@alanya.edu.tr
+90-242-5106060

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion